Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease.

Ridker PM, Lincoff AM, Marx N, Navar AM, Sattar N, Tuttle KR, Budoff M, Böttcher M, Cavender MA, Choudhury RP, Cornel JH, Gajos G, Komuro I, Reddy Parvathareddy KMK, Pontremoli R, Saraiva JFK, Simova II, Sloan LA, López-Suárez A, Tang YD, Tokgözoğlu L, Tsabedze N, Tsioufis K, Verma S, Vrolix M, Andersen A, Baeres FMM, Ekström K, Engelmann MDM, Gerward S, Hovingh GK, Hvelplund A, Perkovic V, ZEUS Investigators

Open source

DOI: 10.1056/nejmoa2612126
Published: 2026 Nov 7
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2612126,
  title = {Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease.},
  author = {Ridker PM and Lincoff AM and Marx N and Navar AM and Sattar N and Tuttle KR and Budoff M and Böttcher M and Cavender MA and Choudhury RP and Cornel JH and Gajos G and Komuro I and Reddy Parvathareddy KMK and Pontremoli R and Saraiva JFK and Simova II and Sloan LA and López-Suárez A and Tang YD and Tokgözoğlu L and Tsabedze N and Tsioufis K and Verma S and Vrolix M and Andersen A and Baeres FMM and Ekström K and Engelmann MDM and Gerward S and Hovingh GK and Hvelplund A and Perkovic V and ZEUS Investigators},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2612126},
  url = {https://doi.org/10.1056/nejmoa2612126}
}

RIS

TY  - JOUR
TI  - Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease.
AU  - Ridker PM
AU  - Lincoff AM
AU  - Marx N
AU  - Navar AM
AU  - Sattar N
AU  - Tuttle KR
AU  - Budoff M
AU  - Böttcher M
AU  - Cavender MA
AU  - Choudhury RP
AU  - Cornel JH
AU  - Gajos G
AU  - Komuro I
AU  - Reddy Parvathareddy KMK
AU  - Pontremoli R
AU  - Saraiva JFK
AU  - Simova II
AU  - Sloan LA
AU  - López-Suárez A
AU  - Tang YD
AU  - Tokgözoğlu L
AU  - Tsabedze N
AU  - Tsioufis K
AU  - Verma S
AU  - Vrolix M
AU  - Andersen A
AU  - Baeres FMM
AU  - Ekström K
AU  - Engelmann MDM
AU  - Gerward S
AU  - Hovingh GK
AU  - Hvelplund A
AU  - Perkovic V
AU  - ZEUS Investigators
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2612126
UR  - https://doi.org/10.1056/nejmoa2612126
ER  -

APA

PM, R., AM, L., N, M., AM, N., N, S., KR, T., M, B., M, B., MA, C., RP, C., JH, C., G, G., I, K., KMK, R. P., R, P., JFK, S., II, S., LA, S., A, L., YD, T., L, T., N, T., K, T., S, V., M, V., A, A., FMM, B., K, E., MDM, E., S, G., GK, H., A, H., V, P., & Investigators, Z. (2026). Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2612126

Source records

pubmed · retrieved 2026-11-10T08:57:22.876Z